title: Activating KIRs in Chronic Lymphoproliferative Disorder of NK Cells: Protection from Viruses and Disease Induction?
abstract: Human natural killer (NK) cells are functionally regulated by killer cell immunoglobulin-like receptors (KIRs) and their interactions with HLA class I molecules. As KIR expression in a given NK cell is stochastically established, KIR repertoire perturbations reflect a dominance of discrete NK-cell subsets as the consequence of adaptation of the NK-cell compartment to exogenous agents, more often represented by virus infection. Although inhibitory interactions between KIR and their cognate HLA class I ligands abrogate effector responses of NK cells, they are also required for the functional education of NK cell. The biology and molecular specificities of the activating KIRs are less well defined, and most interactions with presumed HLA class I ligands are weak. Interestingly, epidemiologic studies link activating KIR genes to resistance against numerous virus infections. Chronic lymphoproliferative disorder of NK cells (CLPD-NK) is an indolent NK cell disease characterized by a persistent increase of circulating NK cells (usually exceeding 500 NK cells/mm(3)). The mechanism through which NK cells are induced to proliferate during CLPD-NK pathogenesis is still a matter of debate. Accumulating data suggest that exogenous agents, in particular viruses, might play a role. The etiology of CLPD-NK, however, is largely unknown. This is likely due to the fact that not a single, specific agent is responsible for the NK cells proliferation, which perhaps represents the expression of an abnormal processing of different foreign antigens, sharing a chronic inflammatory background. Interestingly, proliferating NK cells are typically characterized by expression of a restricted pattern of KIR, which have been demonstrated to be mostly represented by the activating form. This finding indicates that these receptors may be directly involved in the priming of NK cells proliferation.
authors.affiliation: Hematology and Clinical Immunology Branch, Department of Medicine, Padua University School of Medicine , Padua , Italy ; Venetian Institute of Molecular Medicine , Padua , Italy.
authors.forename: Renato
authors.initials: R
authors.lastname: Zambello
authors.affiliation: Hematology and Clinical Immunology Branch, Department of Medicine, Padua University School of Medicine , Padua , Italy ; Venetian Institute of Molecular Medicine , Padua , Italy.
authors.forename: Antonella
authors.initials: A
authors.lastname: Teramo
authors.affiliation: Hematology and Clinical Immunology Branch, Department of Medicine, Padua University School of Medicine , Padua , Italy ; Venetian Institute of Molecular Medicine , Padua , Italy.
authors.forename: Gregorio
authors.initials: G
authors.lastname: Barilà
authors.affiliation: Hematology and Clinical Immunology Branch, Department of Medicine, Padua University School of Medicine , Padua , Italy ; Venetian Institute of Molecular Medicine , Padua , Italy.
authors.forename: Cristina
authors.initials: C
authors.lastname: Gattazzo
authors.affiliation: Hematology and Clinical Immunology Branch, Department of Medicine, Padua University School of Medicine , Padua , Italy ; Venetian Institute of Molecular Medicine , Padua , Italy.
authors.forename: Gianpietro
authors.initials: G
authors.lastname: Semenzato
keywords: CLPD-NK; NK cell licensing; activating KIRs; pathogenesis in NK disorders; viral infections